{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-024097","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2026-05-18T13:00:24+00:00","discovered_at":"2026-05-18T13:01:10.350640+00:00","generated_at":"2026-05-18T13:01:43.375619+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Lipocine to present at A.G.P. Annual Virtual Healthcare Showcase on May 20","bullets":["Fireside chat scheduled for 3:00 PM ET on Wednesday, May 20, 2026.","Investors can register and view the chat via the conference platform.","Lipocine's pipeline includes candidates for postpartum depression, epilepsy, and obesity.","No financial results or business updates were disclosed in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-024097","json":"https://secwatch.observer/filing/0001493152-26-024097.json","markdown":"https://secwatch.observer/filing/0001493152-26-024097.md","text":"https://secwatch.observer/filing/0001493152-26-024097.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226024097/0001493152-26-024097-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226024097/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T13:01:43.375619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}